Funder: Pfizer Inc.
Due Dates: May 5, 2026 (LOI submission) | August 28, 2026 (Full proposal, by invitation)
Funding Amounts: Up to $200,000 per project (max 2 years); total program budget approx. $500,000; 28% overhead cap.
Summary: Supports collaborative quality improvement and research projects to advance migraine care and outcomes for women in the US.
Key Information: LOI is required; only invited applicants may submit full proposals.